Waters Corporation creates business advantages for laboratory-dependent organizations by delivering scientific innovation to enable customers to make significant advancements. Waters helps customers make profound discoveries, optimize laboratory operations, deliver product performance, and ensure regulatory compliance with a connected portfolio of separations and analytical science, laboratory informatics, mass spectrometry, as well as thermal analysis.

At this years WCBP, Waters is excited to offer a sneak preview of our new product - MaxPeak Premier Columns for BioSeparations. Designed for platform SEC methods of simple to complex biotherapeutics, see what you have been missing in chromotography separations! 

Check out our Vendor Seminar.

Tuesday, January 25th 1:00 - 2:00 PM EST - streaming live.

Unbiased Biotherapeutic Analysis: Achieved with Greater Efficiency and Higher Confidence in Results

The goal of unbiased and reproducible biopharmaceutical analysis is fundamental to all stages of drug development, manufacturing, and quality control. For LC and LCMS based analyses, limiting the unwanted effects of analyte-column and analyte-system interactions is a critical element for achieving this goal, as is removing the potential for bias and error during the processing of the results. During our technical session, Waters will discuss recent technological innovations that fundamentally improve bioseparations performance and robustness, and new automated data analysis tools that simplify the generation of higher quality results. These enabling innovations synergize to produce more robust, reproducible, and unbiased analyses for both characterization and monitoring of biotherapeutic attributes. Please join us for a hearty lunch, good science, and a discussion of these new capabilities for biopharmaceutical analysis.

Don't forget to explore our 'Resources' tab for more information on Waters solutions and the NEW MaxPeak Premier Column.